The United Nations Children’s Fund (UNICEF) has been working with researchers at SDSC as well as other parts of UC San Diego to determine the location of existing Liberian schools so they can provide them with resources and work with policy makers to plan future schools.
An engineering-surgery team at UC San Diego is working to extend the reach of surgeons by allowing them to operate remotely on patients located across a city, country, or even the globe. They are developing predictive augmented reality systems that could help make telesurgery a reality.
UC San Diego's Clinical Bioengineering course offers undergraduate engineering students hands-on learning experience to solve clinical problems. The course reflects the Institute of Engineering in Medicine's mission to connect engineers with physicians to produce medical innovations.
Researchers at UC San Diego and Arizona State University have received $1.7 million in funding from The Michael J. Fox Foundation for Parkinson’s Research to launch a multi-year effort to identify blood-based biomarkers of Parkinson’s disease, which could improve care and accelerate new treatments.
UC San Diego researchers studying p53, the heralded cancer-fighting “guardian of the genome,” found that the human protein also plays a role in promoting tumors, in addition to suppressing them.
Organic compounds from perfume, food, fabrics and soaps coat indoor surfaces. The film commonly found in our homes can impact the air we breathe and our health. Yet the details of how these compounds interact microscopically with indoor surfaces are not fully known. Researchers are learning more.
In a study published January 17, 2019 in Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involved in neurodevelopment and associated behaviors.
A team of researchers led by the University of California San Diego has identified a genetic pathway that causes some individuals to develop an abnormal heart rhythm, or arrhythmia, after experiencing a heart attack. They have also identified a drug candidate that can block this pathway.
Using induced pluripotent stem cell-derived neurons from Alzheimer’s patients, UC San Diego researchers say cholesteryl esters — the storage product for excess cholesterol within cells — act as regulators of the protein tau, providing a new druggable target for the disease.
Researchers at University of California San Diego School of Medicine report that autopsies of patients diagnosed with Alzheimer’s disease when they were alive — and confirmed by autopsy — indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.